Luteinizing hormone receptor mutations and sex differentiation

European Journal of Endocrinology

Volumn 134, Issue 5, 1996, Pages 533-540

  Themmen, Axel P N ^a   Brunner, Han G ^b  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; LUTEINIZING HORMONE; LUTEINIZING HORMONE RECEPTOR;

EMBRYO; FEMALE; FETUS; HUMAN; MALE; MOLECULAR BIOLOGY; MUTATION; PRENATAL DEVELOPMENT; PRIORITY JOURNAL; REVIEW; SEX DIFFERENTIATION DISORDER;

EID: 0029979909     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1340533     Document Type: Review

References (60)

1. Bogan JS, Page DC. Ovary? Testis-A mammalian dilemma. Cell 1994:76;603-7
2. Goodfellow PN, Lovell-Badge R. SRY and sex determination in mammals. Annu Rev Genet 1993;27:71-92
3. Josso N, Cate RL, Picard JY, Vigier B, di Clemente N, Wilson C, et al. Anti-mullerian hormone: the Jost factor. Recent Prog Horm Res 1993;48:1-59
4. Baarends WM, van Helmond MJ, Post M, van der Schoot PJ, Hoogerbrugge JW, de Winter JP, et al. A novel member of the transmembrane serine/threonine kinase receptor family is specifically expressed in the gonads and in mesenchymal cells adjacent to the mullerian duct. Development 1994;120:189-97
5. di Clemente N, Wilson C, Faure E, Boussin L, Carmillo P, Tizard R, et al. Cloning, expression, and alternative splicing of the receptor for anti-Mullerian hormone. Mol Endocrinol 1994;8:1006-20
6. Griffin JE, McPhaul MJ, Russel DW, Wilson JD. The androgen resistance syndromes: 5-alpha-reductase 2 deficiency, testicular feminization, and related disorders. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic and molecular bases of inherited disease. New York:McGraw-Hill, 1995;2987-98
7. McPhaul MJ, Marcelli M, Zoppi S, Griffin JE, Wilson JD. Genetic basis of endocrine disease. 4. The spectrum of mutations in the androgen receptor gene that causes androgen resistance. J Clin Endocrinol Metab 1993;76:17-23
8. Huhtaniemi I, Pelliniemi LJ. Fetal Leydig cells: cellular origin morphology, life span, and special functional features. Proc Soc Exp Biol Med 1992;201:125-40
9. Huhtaniemi I. Fetal testis-a very special endocrine organ. Eur J Endocrinol 1994;130:25-31
10. Buehr M, Gu S, McLaren A. Mesonephric contribution to testis differentiation in the fetal mouse. Development 1993;117:273-81
11. Clements JA, Reyes FI, Winter JS, Faiman C. Studies on human sexual development. III. Fetal pituitary and serum, and amniotic fluid concentrations of LH, CG, and FSH, J Clin Endocrinol Metab 1976;42:9-19
12. Segaloff DL, Ascoli M. The lutropin/choriogonadotropin receptor...4 years later. Endocr Rev 1993;14:324-47
13. Segaloff DL, Sprengel R, Nikolics K, Ascoli M. Structure of the lutropin/choriogonadotropin receptor. Recent Prog Horm Res 1990;46:261-301
14. Loosfelt H, Misrahi M, Atger M, Salesse R, Vu Hai-Luu Thi MT, Jolivet A, et al. Cloning and sequencing of porcine LH-hCG receptor cDna: variants lacking transmembrane domain. Science 1989;245:525-8
15. Parmentier M, Libert F, Maenhaut C, Lefort A, Gerard C, Perret J, et al. Molecular clonin of the thyrotropin receptor. Science 1989;246:1620-2
16. Minegishi T, Nakamura K, Takakura Y, Miyamoto K, Hasegawa Y, Ibuki Y, et al. Cloning and sequencing of human LH/hCG receptor cDNA. Biochem Biophys Res Commum 1990; 172:1049-54
17. Sprengel R, Braun T, Nikolics K, Segaloff DL, Seebury PH. The testicular receptor for follicle stimulating hormone: structure and functional expression of cloned cDNA. Mol Endocrinol 1990; 4:525-30
18. 2+ mobilization. Studies with the cloned murine luteinizing hormone receptor expressed in L cells. J Biol Chem 1992;267:4479-88
19. Clark BJ, Wells J, King SR, Stocco DM. The purification, cloning, and expression of a novel luteinizing hormone-induced mitochondrial protein in MA-10 mouse Leydig tumor cells. Characterization of the steroidogenic acute regulatory protein (StAR). J Biol Chem 1994;269:28314-22
20. Lin D, Sugawara T, Strauss JB, Clark BJ, Stocco DM, Saenger P, et al. Role of steroidogenic acute regulatory protein in adrenal and gonadal steroidogenesis. Science 1995;267:1828-31
21. Zhang FP, Hamalainen T, Kaipia A, Pakarinen P, Huhtaniemi I. Ontogeny of luteinizing hormone receptor gene expression in the rat testis. Endocrinology 1994;134:2206-13
22. Sokka T, Hamalainen T, Huhtaniemi L. Functional LH receptor appears in the neonatal rat ovary after changes in the alternative splicing pattern of the LH receptor mRNA. Endocrinology 1992;130:1738-40
23. Huhtaniemi IT, Korenbrot CC, Jaffe RB. HCG binding and stimulation of testosterone biosynthesis in the human fetal testis. J Clin Endocrinol Metab 1977;44:963-7
24. Molsberry RI, Carr BR, Mendelson CR, Simpson ER. Human chorionic gonadotropin binding to human testes as a function of gestational age. J Clin Endocrinol Metab 1982;55:791-4
25. Brinkmann AO, Kuiper GG, Ris-Stalpers C, van Rooij HC, Romalo G, Trifiro M, et al. Androgen receptor abnormalities. J Steroid Biochem Mol Biol 1991;40:349-52
26. Donohoue PA, Parker K, Migeon CJ. Congenital adrenal hyperplasia In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic and molecular bases of inherited disease. New York: McGraw-Hill, 1995:2929-66
27. Schedewie HK, Reiter EO, Beitins IZ, Seyed S, Wooten VD, Jimenez JF, et al. Testicular leydig cell hyperplasia as a cause of familial sexual precocity. J Clin Endocrinol Metab 1981;52:271-8
28. Egli CA, Rosenthal SM, Grumbach MM, Montalvo JM, Gondos B. Pituitary gonadotropin-independent male-limited autosomal dominant sexual precocity in nine generations: familial testotoxicosis. J Pediatr 1985;106:33-40
29. Gondos B, Egli CA, Rosenthal SM, Grumbach MM. Testicular changes in gonadotropin-independent familial male sexual precocity. familial testotoxicosis. Arch Pathol Lab Med 1985;109:990-5
30. Grumbach MM, Styne DM, Puberty: ontogeny, neuroendocrinology, physiology, and disorders. In: Wilson JD, Foster DW, editors. Textbook of Endocrinology. 8th ed. Philadelphia: WB Saunders 1992:733-98
31. Rosenthal SM, Grumbach MM, Kaplan SL. Gonadotropin-independent familial sexual precocity with premature Leydig and germinal cell maturation (familial testotoxicosis): effects of a potent luteinizing hormone-releasing factor agonist and methoxyprogesterone acetate therapy in four cases. J Clin Endocrinol Metab 1983;57:571
32. Manasco PK, Girton ME, Diggs RL, Doppman JL, Feuillan PP, Barnes KM et al. A novel testis-stimulating factor in familial male precocious puberty. N Engl J Med 1991;324:227-31
33. Kjelsberg MA, Cotecchia S, Ostrowski J, Caron MG, Lefkowitz RJ. Constitutive activation of the alpha 1B-adrenergic receptor by all amino acid substitutions at a single site. Evidence for a region which constrains receptor activation. J Biol Chem 1992;267: 1430-3
34. Robbins LS, Nadeau JH, Johnson KR, Kelly MA, Roselli-Rehfuss L, Baack E, et al. Pigmentation phenotypes of variant extension locus alleles result from point mutations that alter MSH receptor function. Cell 1993;72:827-34
35. Kremer H, Mariman E, Otten BJ, Moll Jr G, Stoelinga GB, Wit JM, et al. Cosegregation of missense mutations of the luteinizing hormone receptor gene with familial male-limited precocious puberty. Hum Mol Genet 1993;2:1779-83
36. Shenker A, Laue L, Kosugi S, Merendino Jr J, Minegishi T, Cutler Jr G. A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty. Nature 1993;365:652-4
37. Cotecchia S, Exum S, Caron MG, Lefkowitz RJ. Regions of the alpha 1-adrenergic receptor involved in coupling to phosphatidylinositol hydrolysis and enhanced sensitivity of biological function. Proc Natl Acad Sci USA 1990;87:2896-900
38. Kobilka BK, Kobilka TS, Daniel K, Regan JW, Caron MG, Lefkowitz RJ. Chimeric alpha 2-beta 2-adrenergic receptors: delineation of domains involved ineffector coupling and ligand binding specificity. Science 1988;240:1310-16
39. Ascoli M. Characterizaion of several clonal lines of cultured Leydig tumor cells : gonadotropin receptors and steroidogenic responses. Endocrinology 1981;108:88-95
40. Schwartz M, Imperato-McGinley J, Peterson RE, Cooper G, Morris PL, MacGillivray M et al. Male pseudohermaphroditism secondary to an abnormality in Leydig differentiation. J Clin Endocrinol Metab 1981;53:123-7
41. Perez-Palacios G, Scaglia HE, Kofman-Alfaro S, Saavedra D, Ochoa S, Larraza O, et al. Inherited male pseudohermaphroditism due to gonadotrophin unresponsiveness. Acta Endocrinol (Copenh) 1981;98:148-55
42. Lee PA, Rock JA, Brown TR, Fichman KM, Migeon CJ, Jones Jr H. Leydig cell hypofunction resulting in male pseudohermaphroditism. Fertil Steril 1982;37-675-9
43. el-Awady MK, Temtamy SA, Salam MA, Gad YZ. Familial Leydig cell hypoplasia as a cause of male pseudohermaphroditism. Hum Hered 1987;37:36-40
44. Toledo SP, Arnhold IJ, Luthold W, Russo EM, Saldanha PH. Leydig cell hypoplasia determining familial hypergonadotropic hypogonadism. Prog Clin Biol Res 1985;200:311-4
45. Toledo SP. Leydig cell hypoplasia leading to two different phenotypes: male pseudohermaphroditism and primay hypogonadism not associated with this. Clin Endocrinol 1992;36:521-2
46. Saldanha PH, Arnhold IJ, Mendonca BB Bloise W, Toledo SP. A clinico-genetic investigation of Leydig cell hypoplasia. Am J Med Genet 1987;26:337-44
47. Martinez-Mora J, Saez JM, Toran N, Isnard R, Perez-Iribarne MM, Egozcue J, et al. Male pseudohermaphroditism due to Leydig cell agenesia and absence of testicular LH receptors. Clin Endocrinol 1991;34:485-91
48. Kremer H, Kraaij R, Toledo SPA, Post M, Fridman JB, Hayashida CY, et al. Male pseudohermaphroditism due to a homozygous missense mutation of the luteinizing hormone receptor gene. Nature Gene 1995;9:160-4
49. Laue L, Wu S-M, Kudo M, Hsueh AJW, Cutler GB, Griffin JE, et al. A nonsense mutation of the human luteinizing hormone receptor gene in Leydig cell hypoplasia. Hum Mol Genet 1995;4:1429-33
50. Laue L, Wu SM, Kudo M, Hsueh AJW, Cutler Jr GB, Chan WY. Missense mutations in exons 10 to 11 of the human luteinizing hormone receptor gene are associated with Leydig cell hypoplasia [abstract]. Am J Hum Gene Suppl 1995;57:1252
51. Atger M, Misrahi M, Sar S, Leflem L, Dessen P, Milgrom E. Structure of the human luteinizing hormone choriogonadotropin receptor gene: unusual promoter and 5′ non-coding regions. Mol Cell Endocrinol 1995;111:113-23
52. Strader CD, Fong TM, Tola MR, Underwood D, Dixon RF. Structure and function of G protein-coupled receptors. Annu Rev Biochem 1994;63:101-32
53. Kendall SK, Samuelson LC, Saunders TL, Wood RI, Camper SA. Targeted disruption of the pituitary glycoprotein hormone alpha-subunit produces hypogonadal and hypogonadal mice. Genes Dev 1995;9:2007-19
54. Kraaij R, Post M, Kremer H, Milgrom E, Epping W, Brunner HG, et al. A missense mutation in the second transmembrane segment of the luteinizing hormone receptor causes familial male-limited precocious puberty. J Clin Endocrinol Metab 1995:
55. Laue L, Chan WY, Hsueh AJW, Kudo M, Hsu SY, Wu SM, et al. Genetic heterogeneity of constitutively activating mutations of the human luteinizing hormone receptor in familial male-limited precocious puberty. Proc Natl Acad Sci USA 1995;92:1906-10
56. Laue L , Wu SM, Kudo M, Hsueh AJW, Bourdony CJ, Cutler Jr GB, et al. Heterogeneity of human luteinizing hormone receptor (hLHR) gene mutations in Leydig cell hypoplasia (LCH). Annu Meet Endocr Soc, Washington DC, 1995. Abstract P3-37
57. Latronico A, Anasti J, Mendonca BB, Arnhold I, Domenice S, Albano MC, et al. A novel mutation of the luteinizing hormone receptor gene causing male gonadotropin-independent precocious puberty. Annu Meet Endocr Soc, Washington DC, 1995. Abstract P3-35
58. Yano K, Saji M, Hidaka A, Moriya N, Okuno A, Kohn LD, et al. A new constitutively activating point mutation in the luteinizing hormone/choriogonadotropin receptor gene in cases of male-limited precocious puberty. Annu Meet Endocr Soc, Washington DC, 1995. Abstract P3-33
59. Laue L, Wu SM, Jelly DH, Cutler Jr GB, Chan WY. A novel constitutively activating mtation of the human luteinizing hormone (hLHR) gene in an african American patient with "sporadic" male-limited precocious puberty. Annu Meet Endocr Soc, Washington DC, 1995. Abstract P3-36
60. Kosugi S, van Dop C, Geffner ME, Rabi W, Carel JC, Chaussain JL, et al. Characterization of heterogenous mutations causing constitutive activation of the luteinizing hormone receptor in familial male precocious puberty. Hum Mol Genet 1995;4:183-8